ResApp, created in 1990 (Australia), from
1125 sister brands
and 17477 competing brands.
ResApp is owned by Pfizer Inc, listed on the stock exchange of New York
ResApp belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.